Educational, interpretive, and coaching-support infrastructure. REGNR8 does not diagnose, prescribe, treat, cure, prevent disease, change medication, replace qualified care, or provide emergency support.

REGNR8™ Governed Health Intelligence

Governed Health Intelligence

From complex health information to structured interpretation, bounded programme design, and accountable coaching support.

REGNR8 transforms fragmented health information into safety-controlled reports, locked support architecture, and monitored coaching execution. It helps people and professionals understand patterns, uncertainty, missing context, and appropriate next questions — without diagnosing, prescribing, or replacing qualified care.

Governed
Operating
System
Human Navigator
Interpretation
Coach Designer
Manifest
Coach / Human
Execution
Controlled sourcesPermission-aware retrievalProgram ManifestHuman escalationCase continuity

The problem

Health information is abundant. Safe understanding is not.

Fluency does not guarantee context, permission control, uncertainty, red-flag recognition or safe boundaries.

Generic health AIREGNR8 governed health intelligence
Responds primarily to the promptApplies source, permission and safety controls
May overinterpret isolated findingsRequires context, convergence and uncertainty
May produce treatment-like instructionsSuppresses diagnosis, doses, protocols and medication changes
Often answers onceSupports structured case continuity
Relies heavily on disclaimersBuilds controls into retrieval, reporting and execution

The diagnostic-journey gap

Most diagnostic failures begin before the wrong answer.

They begin when the complete health story is never assembled.

Healthcare now produces more information than ever — symptoms, laboratory results, scans, medication histories, wearable data, practitioner notes, supplement histories, lifestyle changes, family observations, and years of lived experience.

Yet that information is often divided across appointments, providers, specialties, apps, reports, and time. The person is often the only continuous participant in the entire journey, but is expected to reconstruct that complexity during short, episodic encounters.

REGNR8™ is being built for this missing layer. It does not diagnose, prescribe, or replace qualified care. It organises fragmented health information into a governed, longitudinal structure that helps people and professionals see what is known, what has changed, what remains uncertain, and what may require review.

Up to 15%

of diagnoses may be inaccurate, delayed, or wrong in the OECD’s diagnostic-safety analysis.

Most people

are likely to experience at least one diagnostic error during their lifetime, according to the National Academies.

4.7 years

was the average rare-disease diagnostic journey reported in a 2024 European study.

17.5%

of healthcare expenditure is the OECD’s modelled direct burden of misdiagnosis, underdiagnosis, and overdiagnosis in a typical OECD system.

Evidence note These figures arise from different populations and methodologies and should not be added together or represented as one global prevalence estimate.

REGNR8 does not replace diagnosis. It strengthens the journey around it.

REGNR8 is designed to

Organise · Clarify · Preserve context · Surface uncertainty · Improve preparation · Support earlier review · Monitor implementation · Escalate appropriately

REGNR8 does not

Diagnose · Prescribe · Change medication · Replace examination or testing · Override professional judgment · Claim a root cause · Promise recovery · Provide emergency care

The opportunity is not to automate medicine.

It is to prevent critical health information from being lost between the person, the data, and the next decision.

The REGNR8 platform

One governed operating system. Three connected layers.

Each layer has a defined role, authority boundary and safety function.

02

Coach Designer

Converts approved interpretation and context into a locked Program Manifest.

03

Coach Agent / Human Coach

Executes the Manifest through check-ins, simplification, monitoring, escalation and review.

Human Navigator

Complex health information, translated into a calmer map.

Observations, possible interpretations, uncertainty, counter-evidence and missing context are kept distinct.

Illustrative Human Navigator Summary
At a glanceMultiple possible contributors; no established primary cause.
ConfidenceModerate-to-low due to incomplete context.
Counter-evidenceNot all data points support one interpretation.
What would raise confidenceTimeline, medication reconciliation, prior results and clinical assessment.
Professional-review questionsStructured questions remain under qualified authority.
HandoffOnly locked, approved inputs move to Coach Designer.

Programme design

One governed contract between analysis and coaching.

The Program Manifest defines what the Coach may support, what must be monitored and when a human professional must intervene.

State

Home Base, Return Path, Active Module, Pause or Escalate.

Minimum Viable Day

A safe, approved lower-load action when capacity is limited.

Return Path

A controlled simplification route when burden rises.

Human route

Explicit thresholds for review and qualified authority.

Core rule · Personalised does not mean unbounded.

Interactive product demonstration

From report to programme to coached support.

A fixed synthetic journey across all three product layers. No health data is collected or analysed.

Safety & governance

A disclaimer is not a safety system.

REGNR8 places boundaries inside source handling, permissions, reporting, programme design, execution and QA.

Source controls
Permission controls
Vulnerability controls
Medication controls
Protocol controls
Red-flag controls
Claims controls
Human review

What REGNR8 does not do

  • Diagnosis
  • Prescribing
  • Medication changes
  • Supplement dosing
  • Treatment protocols
  • Cure claims
  • Clinician replacement
  • Emergency down-triage
  • Single-marker certainty
  • Patient-executable health plans

For partners

Governed infrastructure for different roles.

Clinicians

Structured summaries, unresolved questions, context and handover support.

Human Coaches

Manifest-led check-ins, burden tracking, Return Path and escalation summaries.

Institutions

Role separation, permissions, audit, case continuity and controlled pilots.

Investors

Reusable governance infrastructure, monitoring, QA and human-supervised learning.

Investor overview · v1.1

The asset is not the base model.
The asset is the governed operating system around it.

REGNR8 is building governed health-intelligence infrastructure for safer interpretation, bounded programme design, accountable coaching support, and longitudinal case continuity.

REGNR8 at a glance

How the translation layer works.

This investor infographic visually connects fragmented health inputs, the governed workflow, the commercial rationale and the safe round snapshot.

REGNR8 visual overview showing fragmented health inputs moving through governed convergence, a coach-designed programme, coaching, feedback and refinement, alongside investor rationale and a safe investment snapshot
Illustrative investor overview of the REGNR8 translation layer and investment proposition.

Investment snapshot

A focused proof-conversion round.

Capital is intended to move REGNR8 from governed internal proof toward productisation, pricing validation, pilot readiness and stronger evidence for the next financing stage.

RaiseUSD $1,000,000
Primary capitalUSD $825,000
Founder-support secondaryUSD $175,000Excluded from operating runway
Pre-money valuationUSD $24,000,000Management fundraising anchor
Post-money valuationUSD $25,000,000Derived on a strict post-money basis

Round purpose Productisation, governance formalisation, pricing validation, pilot readiness, and next-raise evidence.

Current investment entity Executive Athlete Lab (Pty) Ltd, subject to definitive legal documentation.

Future structure A possible Delaware parent or reorganisation may be considered if commercially required and lawfully implemented.

Valuation boundaryThe $24M pre-money valuation is a management fundraising anchor, not a certified valuation, independent valuation opinion, securities-law conclusion, investment advice, or guarantee of investor return.

Why now

Fluent answers are not accountable infrastructure.

Health information has outpaced interpretation. Consumers, practitioners, institutions and payers need support that is structured, governed and auditable—not another generic AI health chatbot.

01

Information overload

More health information does not automatically create better understanding, prioritisation or continuity.

02

Governance gap

General-purpose AI can sound confident without approved sources, bounded claims, permission controls or accountable review.

03

Infrastructure need

Serious health partners require structured outputs, traceability, human oversight and evidence that can survive review.

Commercial model

Sequence the market. Prove the system.

The current round focuses on health productisation and proof conversion. Channel timing remains subject to product, regulatory, claims-boundary and commercial review.

First

Consumer

Validate usability, willingness to pay, continuity and coaching-support value in a controlled offer.

Second

Institutional

Develop evidence-led pathways for payers, employers, health partners and governed pilots.

Third

Practitioner

Enable qualified professionals with structured interpretation, programme and handover infrastructure.

Illustrative management model

Year 5 revenue mix assumption

USD $29.82M total: consumer $17.892M (60%), institutional $10.437M (35%) and practitioner $1.491M (5%).

This is an assumption-dependent management model for planning discussion. It is not a forecast, promise, certified outcome or guarantee of performance.

Use of funds

Primary capital allocation.

Management plan based on USD $825,000 primary capital. Categories and allocations remain subject to diligence, legal review, execution needs and board or management approval.

Productisation$255K · 30.9%
Commercial validation$145K · 17.6%
Legal / regulatory / claims-boundary$100K · 12.1%
Pilot delivery$105K · 12.7%
Technology infrastructure$85K · 10.3%
Operations$80K · 9.7%
Reserve / contingency$55K · 6.7%

Milestones funded

An 18-month de-risking path.

Timing is a management target and remains dependent on financing close, review outcomes, execution conditions and partner availability.

Months 1–6

Productised platform live

Months 1–8

Legal, regulatory and claims-boundary clarity

Months 6–12

Early paid traction and pricing evidence

Months 9–15

Institutional pathway

Months 12–18

Next-raise readiness

Public document index

What approved investors can review.

This public section shows the categories of material available. It does not expose the documents themselves. Confidential materials are released only after request, eligibility review, NDA where required and management approval.

Business

Business Plan

Strategy, market, operating model and execution assumptions.

Confidential · gated
Investment

Investor Appendix

Round context, assumptions and supporting review material.

Confidential · gated
Snapshot

Investor Snapshot

Safer round summary with valuation and entity boundaries.

Previewed publicly · full file gated
Evidence

Governed Digestive Intelligence Evidence Pack

Source and evidence-governance demonstration.

Confidential · gated
Product

Human Navigator sample report

De-identified, bounded interpretation output.

De-identified · gated
Product

Program Manifest sample

Approved programme object and execution boundaries.

Confidential · gated
Journey

Coach Agent journey mockup

State-aware coaching, monitoring and escalation flow.

Confidential · gated
Finance

Use-of-funds schedule

Primary-capital allocation and management assumptions.

Confidential · gated
Valuation

Valuation support summary

Management rationale and review boundaries.

Confidential · gated
Restricted

Illustrative return sensitivities

Not displayed publicly. Any restricted scenario is illustrative only and depends on dilution, future financing, churn, pricing, timing, tax, costs, execution, regulation and exit-market conditions.

Restricted · not a promise or forecast
Briefing

Founder briefing request

Discuss the operating system, proof path, risks and round context directly.

Request a briefing →
Restricted diligence

Risk Register & De-risking Plan

Detailed risks, current posture, mitigation actions and formal review gates are not displayed on the public page.

Restricted · approved investor access only
Access-controlledNDA where requiredWatermarked distributionAccess loggingNo personal health information

Founder + systems architect

The integrator behind REGNR8™.

Peter Smanjak is the originating founder and systems architect of REGNR8™, a governed health-intelligence infrastructure platform designed to preserve practitioner knowledge, structure complex health information, and support safer human-reviewed decisions.

Peter brings approximately 35 years of founder-supplied experience across consulting, healthcare, risk management, decision modelling, entrepreneurship, leadership, management, and multidisciplinary systems development. His distinctive contribution is the ability to identify the architecture beneath complex domains and translate that architecture into governed, traceable, reusable digital systems.

The asset is not the base model. It is the governed operating system around it.
Systems integration
Long-horizon persistence
Governance-first thinking
High productive drive
Direct strategic leadership
Human-centred technology stewardship

Evidence boundary Founder profile material is candidate investor copy. Founder confirmation, legal review, evidence verification, and final website approval are required before publication.

Investor access

Start a confidential review.

Tell us who you represent and what you would like to review. Access is subject to eligibility, confidentiality and management approval.

Before you submit

Do not include personal health information, patient data or clinical records. This prototype confirms the interaction but does not transmit or store your submission.

Do not submit personal health information.
Prototype request confirmed. This sample does not transmit or store the form information.

Investor disclaimer

This website is for general information and confidential investor discussion only. It is not an offer of securities, investment advice, legal advice, tax advice, accounting advice, medical advice, or a guarantee of product performance or investor return. All investment discussions are subject to definitive documentation, eligibility checks, legal review, securities-law review, valuation review, claims-boundary review, and professional advice.

Health disclaimer

REGNR8 provides educational, interpretive, and coaching-support infrastructure. It does not diagnose, prescribe, treat, cure, prevent disease, change medication, replace qualified care, or provide emergency support.

See how governed health intelligence works in practice.